Abstract | PURPOSE: METHODS: RESULTS: CONCLUSIONS: In dry eyes, where sodium hyaluronate monotherapy was insufficient, diquafosol tetrasodium was effective in improving objective and subjective symptoms, suggesting its viability as an option for the additive treatment of such eyes.
|
Authors | K Kamiya, M Nakanishi, R Ishii, H Kobashi, A Igarashi, N Sato, K Shimizu |
Journal | Eye (London, England)
(Eye (Lond))
Vol. 26
Issue 10
Pg. 1363-8
(Oct 2012)
ISSN: 1476-5454 [Electronic] England |
PMID | 22878452
(Publication Type: Journal Article, Multicenter Study, Randomized Controlled Trial)
|
Chemical References |
- Fluorescent Dyes
- Ophthalmic Solutions
- Polyphosphates
- Purinergic P2Y Receptor Agonists
- Uracil Nucleotides
- Viscosupplements
- Rose Bengal
- diquafosol
- Hyaluronic Acid
- Fluorescein
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Drug Therapy, Combination
- Dry Eye Syndromes
(drug therapy, metabolism, physiopathology)
- Female
- Fluorescein
(metabolism)
- Fluorescent Dyes
(metabolism)
- Humans
- Hyaluronic Acid
(administration & dosage, adverse effects)
- Male
- Middle Aged
- Ophthalmic Solutions
- Polyphosphates
(administration & dosage, adverse effects)
- Prospective Studies
- Purinergic P2Y Receptor Agonists
(administration & dosage, adverse effects)
- Rose Bengal
(metabolism)
- Tears
(chemistry)
- Uracil Nucleotides
(administration & dosage, adverse effects)
- Viscosupplements
(administration & dosage, adverse effects)
|